Memantine vs Upadacitinib

## Memantine vs Upadacitinib: Overview

This comparison examines the pharmacological differences between **Memantine** and **Upadacitinib**.

## Mechanism of Action

**Memantine**: Non-competitive NMDA receptor antagonist.

**Upadacitinib**: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

## Pharmacokinetics

**Half-life**: Memantine — 60-80 hours; Upadacitinib — 9-14 hours.

## Chemical Properties

**Molecular Formula**: Memantine — C12H21N; Upadacitinib — C17H19F3N6O.

**Molecular Weight**: Memantine — 179.3080 g/mol; Upadacitinib — 380.3700 g/mol.

**Type**: Memantine — Small molecule; Upadacitinib — Small molecule.